Fangzhou Inc. and Innovent Biologics Forge Strategic Alliance for AI-Driven Weight Management Solutions

Reuters
Sep 10
Fangzhou Inc. and <a href="https://laohu8.com/S/IVBIY">Innovent Biologics</a> Forge Strategic Alliance for AI-Driven Weight Management Solutions

Fangzhou Inc., a leader in AI-driven Internet healthcare solutions, has entered a strategic partnership with Innovent Biologics to enhance weight management solutions. This alliance aims to integrate Fangzhou's AI-enabled "H2H" digital healthcare ecosystem with Innovent's innovative therapies for diabetes and obesity. The collaboration will focus on deploying AI tools like the "XS Core" AI large language model to provide personalized digital care and improve patient education. Innovent's weight management therapy, Mazdutide, which has shown significant health benefits, will be accessible through this partnership. The companies plan to further their collaboration in AI-powered health management, aiming to improve chronic disease care in China.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fangzhou Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9526593-en) on September 10, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10